GROW BRANDS REDUCE COMMERCIAL RISK IMPROVE ROI GET RESULTS
  • Interpace Diagnostics

  • Commercial Services

LATEST NEWS
  • 03/27/2015 - PDI, Inc. Subsidiary Interpace Diagnostics Announces New Data Supporting Use of ThyraMIR™
  • 03/27/2015 - PDI Reports Fourth Quarter and Full Year 2014 Financial Results
  • 02/09/2015 - The Evolving CSO Landscape
  • 02/04/2015 - PDI, Inc. Subsidiary Interpace Diagnostics Announces PancraGen™ Benefits Reinforced in Pivotal Study
  • 12/17/2014 - PDI, Inc. Subsidiary Interpace Diagnostics Announces Launch of ThyGenXTM Next-Generation Sequencing